Filing Details
- Accession Number:
- 0001179110-20-011737
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-07 18:42:10
- Reporting Period:
- 2020-12-03
- Accepted Time:
- 2020-12-07 18:42:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1583107 | Theravance Biopharma Inc. | TBPH | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1668718 | D Philip Worboys | C/O Theravance Biopharma Us, Inc. 901 Gateway Boulevard South San Francisco CA 94080 | Svp, Research & Transl Science | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2020-12-03 | 4,246 | $18.00 | 319,395 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Billionaire Hedge Funds
